Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NTI Announcements
Approval received for NTI164 Phase 3…
NTI
NEUROTECH INTERNATIONAL LIMITED
Market sensitive
Approval received for NTI164 Phase 3 Clinical Study in ASD
Date and time
2 February 2026 at 8:36 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Health Care Equipment & Services
View on ASX
Open original PDF
NTI announcement history
Recent NTI announcements
Appointment of Executive Chairman
Becoming a substantial holder
Secondary Trading Notice
Application for quotation of securities - NTI
Proposed issue of securities - NTI
Proposed issue of securities - NTI